Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01320969 · ClinicalTrials.gov registry record · NA
Could Meditation Modulate the Neurobiology of Learning Not to Fear?
A NA study of Healthy Individuals and Highly Stressed, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
- 1
- Study location
NCT01320969 is a NA study of Healthy Individuals and Highly Stressed that has completed, run by Massachusetts General Hospital. The registered enrollment target is 85 participants, below the 97-participant average among 3 other Healthy Individuals trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01320969, a NA study of Healthy Individuals and Highly Stressed, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
- 1
- Study location
Study Summary
It is well-established that the practice of mindfulness meditation leads to improvements in mental health and well-being and the cultivation of positive emotions. However, the neural mechanisms of these improvements are largely unknown. A few recent studies suggest that mindfulness meditation impacts the structure and function of the ventromedial prefrontal cortex, the hippocampus, and the amygdala. Interestingly, recent studies have shown that these regions are part of a brain circuit that is critical for the extinction of conditioned fear responses, and for the retention of fear extinction memory. Building on the overlap of these regions and on conceptual considerations, the project investigates whether mindfulness meditation could influence one's capacity to retain the memory of fear extinction. Meditation-naïve participants will be randomized to either a mindfulness-meditation based training or an active control training that controls for all mindfulness-unspecific components. Participants will undergo a fear conditioning, extinction and extinction recall protocol in an MRI scanner before and after the trainings. We hypothesize that participants who have practiced mindfulness meditation will show greater improvements in fear extinction memory after the course, and that these improvements will be correlated with anatomical and functional changes in the brain regions of interest. Improvements in fear extinction memory will also be related to improvements in self-reported psychological well-being. Merging the fields of an ancient spiritual tradition and a fundamental learning mechanism, the project investigates the underlying neural mechanisms of a practice for the enhancement of mental health and well-being.
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness-Based Stress Reduction course
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Charlestown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01320969
The ClinicalTrials.gov registry entry for NCT01320969 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 97-participant average among 3 other Healthy Individuals trials with a reported enrollment target (12% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Healthy Individuals appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness-Based Stress Reduction course is the first listed.
NCT01320969 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01320969 about?
NCT01320969 is a clinical study titled "Could Meditation Modulate the Neurobiology of Learning Not to Fear?". It is well-established that the practice of mindfulness meditation leads to improvements in mental health and well-being and the cultivation of positive emotions. However, the neural mechanisms of these improvements are largely unknown. A few recent studies suggest that mindfulness meditation impact...
What is the current status of trial NCT01320969?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2010-12. Estimated completion is 2012-05.
What conditions does trial NCT01320969 study?
This clinical trial studies the following conditions: Healthy Individuals, Highly Stressed.
What interventions are being tested in trial NCT01320969?
The interventions under investigation include: Mindfulness-Based Stress Reduction course (BEHAVIORAL).
Who is sponsoring clinical trial NCT01320969?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01320969 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Individuals
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Sensory Electrical Stimulation on Sensation and Tremor
ACTIVE NOT RECRUITING · NA
-
The Effects of Orally Ingesting Branched Chained Amino Acids on Delayed Onset Muscle Soreness in Diabetic Patients
COMPLETED · NA
-
The Contributions of Age Related Changes in the Sound Localization Pathway to Central Hearing Loss
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.